WINSLOW GARRETT (General Counsel) sold 12.1% of their position (255.00 shares) of DAMORA THERAPEUTICS, INC. on the open market
Open‑market sale worth $5.5K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/6/2026ACC: 0001193125-26-004568
Officer· General Counsel
Since May 2021
-255.00
Net shares
Net seller
$5.5K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
680.00 acquired · 935.00 disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+680.00
Price / share
—
Trade value
—
% of position
47.6%
1/2/2026
1.43K→2.11K
Common Stock
Direct
Shares
−255.00
Price / share
$21.38
Trade value
$5.45K
% of position
12.1%
1/2/2026
2.11K→1.85K
Total
Net shares
+425.00
Net value
-$5.45K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/2/2026 | M · Option Exercise | +680.00 | — | — | 47.6% | 1.43K | 2.11K |
| Common Stock Direct | 1/2/2026 | S · Sale | −255.00 | $21.38 | $5.45K | 12.1% | 2.11K | 1.85K |
| Total | +425.00 | -$5.45K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
680.00 shares
Shares
−680.00
Strike price
Held after
1.32K
Exercisable
—
1/2/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock680.00 shares | 1/2/2026 | M · Option Exercise | −680.00 | — | 1.32K |